• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cassava Sciences, Inc. - Common Stock (NQ:SAVA)

2.450 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cassava Sciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
38 39 Next >
News headline image
Cassava Sciences Says DOJ Has Closed Probe Into Allegations Around Its Alzheimer’s Program ↗
February 19, 2026
The probes into the company by both the DOJ and the SEC have now been closed. 
Via Stocktwits
Topics Regulatory Compliance
News headline image
Cassava Announces Closure of U.S. Department of Justice Investigation
February 19, 2026
From Cassava Sciences, Inc.
Via GlobeNewswire
News headline image
Cassava Announces Publication of Peer-Reviewed Phase 3 Results for Simufilam in Alzheimer’s Disease in the Journal of Prevention of Alzheimer’s Disease
January 13, 2026
From Cassava Sciences, Inc.
Via GlobeNewswire
News headline image
Cassava Announces Agreement to Settle Securities Class Action Litigation
December 23, 2025
From Cassava Sciences, Inc.
Via GlobeNewswire
News headline image
Cassava Sciences Stock On Track For Worst Day In About 9 Months — What’s Driving Today’s Selloff? ↗
December 19, 2025
FDA placed a clinical hold on the proposed proof-of-concept clinical trial for Simufilam in tuberous sclerosis complex -related epilepsy earlier this week. 
Via Stocktwits
News headline image
Which stocks are gapping on Friday? ↗
December 19, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Friday. Let's explore the market movements and identify the stocks with significant gaps. 
Via Chartmill
News headline image
Get insights into the top gainers and losers of Monday's after-hours session. ↗
November 24, 2025
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
Cassava Reports Q3 2025 Financials Results and Provides Business Update
November 12, 2025
From Cassava Sciences, Inc.
Via GlobeNewswire
News headline image
Halper Sadeh LLC Encourages Cassava Sciences, Inc. Shareholders to Contact the Firm to Discuss Their Rights
October 22, 2025
From Halper Sadeh LLC
Via Business Wire
News headline image
Cassava Sciences Appoints Dawn C. Bir to the Board of Directors
October 22, 2025
From Cassava Sciences, Inc.
Via GlobeNewswire
News headline image
Which stocks have an unusual volume on Thursday? ↗
September 25, 2025
Let's have a look at the stocks with an unusual volume in today's session. 
Via Chartmill
News headline image
Peraso Inc. (NASDAQ: PRSO) Regains Nasdaq Compliance, Earns $2.74 Price Target from Intro-act – More Stocks Inside
September 24, 2025
Via AB Newswire
News headline image
In today's session, these stocks are experiencing unusual volume. ↗
September 24, 2025
In today's session, these stocks are experiencing unusual volume. 
Via Chartmill
News headline image
Cassava Sciences (SAVA) Soars 18% After CEO's Substantial Investment
September 23, 2025
Cassava Sciences (NASDAQ: SAVA) witnessed a dramatic surge in its stock price today, climbing an impressive 18% after its President and CEO, Richard Barry, disclosed a significant personal investment... 
Via MarketMinute
Topics Regulatory Compliance
News headline image
Tuesday's session: top gainers and losers ↗
September 23, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
September 23, 2025
 
Via Benzinga
News headline image
Keep an eye on the top gainers and losers in Tuesday's session. ↗
September 23, 2025
Stay up-to-date with the latest market trends in the middle of the day on Tuesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
News headline image
These stocks are gapping in today's session ↗
September 23, 2025
Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Cassava Sciences (SAVA) Stock Is Surging Tuesday: What's Going On? ↗
September 23, 2025
Cassava Sciences shares are trading higher Tuesday morning. A Form 4 filing disclosed that CEO Rick Barry acquired 237,941 shares at an average price of $2.25 each. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
September 23, 2025
 
Via Benzinga
News headline image
Why Super League Enterprise Shares Are Trading Higher By 200%; Here Are 20 Stocks Moving Premarket ↗
September 23, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
September 22, 2025
 
Via Benzinga
News headline image
Curious about the stocks that are showing activity after the closing bell on Monday? ↗
September 22, 2025
As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
News headline image
Cassava Sciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
August 25, 2025
From Cassava Sciences, Inc.
Via GlobeNewswire
News headline image
Cassava Sciences Posts Q2 Loss on Pivot ↗
August 14, 2025
Via The Motley Fool
Topics Intellectual Property
News headline image
Cassava Reports Q2 2025 Financials Results and Provides Business Update
August 14, 2025
From Cassava Sciences, Inc.
Via GlobeNewswire
News headline image
Cassava Sciences Appoints Dr. Joseph Hulihan as Chief Medical Officer
August 07, 2025
From Cassava Sciences, Inc.
Via GlobeNewswire
News headline image
Cassava Sciences Reports Positive Preclinical Study Evaluating Simufilam for TSC-Related Epilepsy
August 04, 2025
From Cassava Sciences, Inc.
Via GlobeNewswire
News headline image
Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting
June 30, 2025
From Cassava Sciences, Inc.
Via GlobeNewswire
News headline image
Cassava Reports Q1 2025 Financials Results, Provides Business Update
May 08, 2025
From Cassava Sciences, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
38 39 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap